Antonio Maria Cazzani
The serotonergic system in L-DOPA-induced dyskinesia: pre-clinical evidence and clinical perspective
Manolo Carta;
2018-01-01
Abstract
During the last decade, the serotonergic system has emerged as a key player in the appearance of L-DOPA-induced dyskinesia in animal models of Parkinson's disease. Clinical investigations, based on imaging and postmortem analyses, suggest that the serotonin neurons are also involved in the etiology of this complication of long-term L-DOPA treatment in parkinsonian patients. These findings have stimulated efforts to develop new therapies using drugs targeting the malfunctioning serotonin neurons. In this review, we summarize the experimental and clinical data obtained so far and discuss the prospects for further development of this therapeutic strategy.File | Size | Format | |
---|---|---|---|
Carta & Bjorklund, JNT, 2018.pdf Solo gestori archivio
Size 725.18 kB
Format Adobe PDF
|
725.18 kB | Adobe PDF | & nbsp; View / Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.